PR Newswire: news distribution, targeting and monitoring

See more news releases in: Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, FDA Approval

 

AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents

 

NEW YORK, April 8 /PRNewswire/ -- Adolescence is a challenging time that is full of changes, during which, some teenagers may experience a debilitating illness known as depression. The good news is that depression is treatable. Here's more about a treatment newly approved for adolescents dealing with depression.

Listen to this report from Forest Pharmaceuticals at:

http://inr.mediaseed.tv/oneClip_C/?feed=pBSDLDiuyUbscPNDurylRMlt_HeO_e9w

Registered journalists can access video, audio, text, graphics and photos for free and unrestricted use at http://www.mediaseed.tv.

04NY09-0075

SOURCE Medialink; Forest Pharmaceuticals

Back to top

RELATED LINKS
http://www.mediaseed.tv

Next in Health Care & Hospitals News

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

Featured Video

 
  • Print
  • Email
  •   RSS
  • Share it 
  • Blog it 
  • Blog Search 

More in These Categories

Advanced Search
Search
  
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. For bloggers
  6. Global sites
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire